Home >> Industry News >> Health Canada approves Corista DP3 platform

Health Canada approves Corista DP3 platform

image_pdfCreate PDF

The platform is CE marked under the European in vitro diagnostic medical devices regulation for use in routine diagnosis in the European Union and United Kingdom. The company announced in December a strategic partnership with Mortsel, Belgium-based Agfa HealthCare.

CAP TODAY
X